A PHARMACEUTICAL COMPOSITION COMPRISING ERYTHROPOIETIN AND CEFTRIAXONE AND A USE THEREOF IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PARKINSONS DISEASE DEMENTIA
#$%^&*AU2016202491A120161110.pdf#####ABSTRACT OF THE DISCLOSURE The invention discloses a pharmaceutical composition for treating Parkinsons disease dementia (PDD), which including erythropoietin and ceftriaxone. The invention also discloses a use of the 5 pharmaceutical composition in the manufacture of a medicament for the treatment of PDD.